The deeper danger that concerns the author is that anti-biotics, more and more often, are failing to work in people treated with them because they are overused.
These are the China microcaps that are either getting sued by shareholders as is the case with Gulf Resources facing the very real threat of delisting as is the case with China Biotics or highly volatile and highly speculative hedge fund trades.